Here, we report a case of lung adenocarcinoma with sarcomatoid differentiation and marked thrombocytosis harboring concurrent JAK2 V617F, TP53, and MET exon 14 skipping mutations, aiming to describe its clinical course and explore the potential association between tumor activity and platelet dynamics. Here, MET is linked to Thrombocytosis.